If this box remains here for more than 30 seconds, click this link to try again.
Products & Services ╗
Best Practice Database
Business Operations ╗ Corporate Libraries
Download FREE Excerpt
6 Info Graphics
13 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Shrinking budgets and increasing responsibilities add to the complexities of handling corporate library operations. Best Practices, LLC undertook this study to understand how benchmarked libraries balance budget, resource and service levels in their organization. Metrics and insights in the document will help corporate library managers in allocating the cost and staff hours to various activities. Corporate libraries can benchmark the financial resources, cost recovery practices and penetration of potential user base at their companies with those at leading organizations within the biopharmaceutical and medical device industries.
People Allocation: Participants allocate the most FTE hours (average 35%) to reference and research services, followed by electronic resources management at 23%. In the Pharma Segment, more FTE hours went to e-resource management (28%) than to reference & research services (27%). Print-related services took only 4% of hours for benchmark participants overall and 5% for the Pharma Segment.
Twenty companies participated in this benchmarking study, with 12 representing the pharmaceutical/ biotech industries, 4 representing the medical device industry, and 4 representing other healthcare businesses.
Health Care; Pharmaceutical; Diagnostic; Consulting; Research; Laboratories; Medical Device; Orthopaedics; Biotech; Chemical
Abbott; Health Advances; Parexel; Pacific Northwest; Novo Nordisk; Tufts Center for the Study of Drug Development; Zimmer; Daiichi Sankyo; Takeda Pharmaceuticals; Boston Scientific; Teva Pharmaceutical Industries Ltd; Eisai; Vertex Pharmaceuticals; Celgene; Ipsen; Astellas; Covidien; Lilly; Boehringer Ingelheim; Cubist Pharmaceuticals